One study showed that injections of semaglutide (the active ingredient in Wegovy), which is administered for diabetes or weight loss in the skin of the abdomen, thigh or upper arm, produced little to no injectionsite pain
In the trial that pitted Foundayo against dapagliflozin, the highest dose of Foundayo reduced blood sugar levels by up to 1.7 percentage points versus 0.8 points for dapagliflozin, with 7.3% weight loss versus 3.0% In the third trial, which tested Foundayo on top of insulin glargine, blood sugar levels dropped up to 2.1 points versus 0.8 points for placebo plus insulin, with 6.1% weight loss versus a slight gain
This is common in chronic diseases such as infections, cancer, and inflammation
Months 5 through 8 (1.7 to 2.4 mg phase) Total weight loss approaches the 12 to 15% range documented in clinical trials
Research suggests that a significant portion is excreted unchanged in the urine, with some undergoing colonic fermentation
Date, time, injection site, and any symptoms in the 48 hours after